197 related articles for article (PubMed ID: 16280008)
1. Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.
Corry GN; Underhill DA
Pigment Cell Res; 2005 Dec; 18(6):427-38. PubMed ID: 16280008
[TBL] [Abstract][Full Text] [Related]
2. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
Watanabe A; Takeda K; Ploplis B; Tachibana M
Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
[TBL] [Abstract][Full Text] [Related]
3. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.
Bondurand N; Pingault V; Goerich DE; Lemort N; Sock E; Le Caignec C; Wegner M; Goossens M
Hum Mol Genet; 2000 Aug; 9(13):1907-17. PubMed ID: 10942418
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10.
Verastegui C; Bille K; Ortonne JP; Ballotti R
J Biol Chem; 2000 Oct; 275(40):30757-60. PubMed ID: 10938265
[TBL] [Abstract][Full Text] [Related]
5. Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects.
Yang T; Li X; Huang Q; Li L; Chai Y; Sun L; Wang X; Zhu Y; Wang Z; Huang Z; Li Y; Wu H
Clin Genet; 2013 Jan; 83(1):78-82. PubMed ID: 22320238
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.
Potterf SB; Furumura M; Dunn KJ; Arnheiter H; Pavan WJ
Hum Genet; 2000 Jul; 107(1):1-6. PubMed ID: 10982026
[TBL] [Abstract][Full Text] [Related]
7. The value of MLPA in Waardenburg syndrome.
Milunsky JM; Maher TA; Ito M; Milunsky A
Genet Test; 2007; 11(2):179-82. PubMed ID: 17627390
[TBL] [Abstract][Full Text] [Related]
8. The PAX3 paired domain and homeodomain function as a single binding module in vivo to regulate subnuclear localization and mobility by a mechanism that requires base-specific recognition.
Corry GN; Raghuram N; Missiaen KK; Hu N; Hendzel MJ; Underhill DA
J Mol Biol; 2010 Sep; 402(1):178-93. PubMed ID: 20643146
[TBL] [Abstract][Full Text] [Related]
9. The mutational spectrum in Waardenburg syndrome.
Tassabehji M; Newton VE; Liu XZ; Brady A; Donnai D; Krajewska-Walasek M; Murday V; Norman A; Obersztyn E; Reardon W
Hum Mol Genet; 1995 Nov; 4(11):2131-7. PubMed ID: 8589691
[TBL] [Abstract][Full Text] [Related]
10. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo.
Pruitt SC; Bussman A; Maslov AY; Natoli TA; Heinaman R
Gene Expr Patterns; 2004 Oct; 4(6):671-85. PubMed ID: 15465489
[TBL] [Abstract][Full Text] [Related]
11. Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome.
Corry GN; Hendzel MJ; Underhill DA
Hum Mol Genet; 2008 Jun; 17(12):1825-37. PubMed ID: 18325909
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of a novel mutation in the PAX3 gene associated with Waardenburg syndrome type I.
Niu Z; Li J; Tang F; Sun J; Wang X; Jiang L; Mei L; Chen H; Liu Y; Cai X; Feng Y; He C
Gene; 2018 Feb; 642():362-366. PubMed ID: 29158168
[TBL] [Abstract][Full Text] [Related]
13. A cascade of genes related to Waardenburg syndrome.
Tachibana M
J Investig Dermatol Symp Proc; 1999 Sep; 4(2):126-9. PubMed ID: 10536986
[TBL] [Abstract][Full Text] [Related]
14. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.
Galibert MD; Yavuzer U; Dexter TJ; Goding CR
J Biol Chem; 1999 Sep; 274(38):26894-900. PubMed ID: 10480898
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2.
Tassabehji M; Read AP; Newton VE; Patton M; Gruss P; Harris R; Strachan T
Nat Genet; 1993 Jan; 3(1):26-30. PubMed ID: 8490648
[TBL] [Abstract][Full Text] [Related]
16. Mutations in PAX3 associated with Waardenburg syndrome type I.
Baldwin CT; Lipsky NR; Hoth CF; Cohen T; Mamuya W; Milunsky A
Hum Mutat; 1994; 3(3):205-11. PubMed ID: 8019556
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal effect of Waardenburg syndrome mutations on DNA binding by the Pax-3 paired domain and homeodomain.
Fortin AS; Underhill DA; Gros P
Hum Mol Genet; 1997 Oct; 6(11):1781-90. PubMed ID: 9302254
[TBL] [Abstract][Full Text] [Related]
18. [Clinical and molecular genetic investigation of Waardenburg syndrome type 1].
Markova TG; Megrelishvilli SM; Shevtsov SP; Shvarts EI
Vestn Otorinolaringol; 2003; (1):17-9. PubMed ID: 12666593
[TBL] [Abstract][Full Text] [Related]
19. [Clinical classification and genetic mutation study of two pedigrees with type II Waardenburg syndrome].
Chen Y; Yang F; Zheng H; Zhu G; Hu P; Wu W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):810-3. PubMed ID: 26663054
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new class of PAX3-FKHR target promoters: a role of the Pax3 paired box DNA binding domain.
Zhang L; Wang C
Oncogene; 2007 Mar; 26(11):1595-605. PubMed ID: 16964289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
